ライフサイエンスコーパス: regulatory agency

1 he maximum residue limits established by the regulatory agency.

2 nd for approval of new therapeutic agents by regulatory agencies.

3 researchers, drug-development programs, and regulatory agencies.

4 fortified foods is mandatory by many global regulatory agencies.

5 e opioids because of possible sanctions from regulatory agencies.

6 e types of events that should be reported to regulatory agencies.

7 e coordination and cooperation with national regulatory agencies.

8 tant and may provide support for approval by regulatory agencies.

9 reparing product data for review by national regulatory agencies.

10 s the utility of DNA barcoding as a tool for regulatory agencies.

11 utical ingredients approved by FDA and other regulatory agencies.

12 y liver disease (NAFLD) has been approved by regulatory agencies.

13 ented by clinicians, academia, industry, and regulatory agencies.

14 r more stringent drinking water standards by regulatory agencies.

15 ntion from researchers, drug developers, and regulatory agencies.

16 ally below benchmark values commonly used by regulatory agencies.

17 in antifibrotic trials will be acceptable to regulatory agencies.

18 utical industry and requirements of national regulatory agencies.

19 rdized aggregate safety reports submitted to regulatory agencies.

20 against the requirements and suggestions of regulatory agencies.

21 battery is a major challenge to industry and regulatory agencies.

22 ed for approval of new therapeutic agents by regulatory agencies.

23 epted by several international water quality regulatory agencies.

24 erm may involve clinical trial validation by regulatory agencies.

25 th care quality consortia, and standards and regulatory agencies.

26 s with the air permitting process and inform regulatory agencies about potential permitting pathways

27 ernment (including both research funding and regulatory agencies), academia, and patient groups to di

28 rmaceutical industry, financial markets, and regulatory agencies alike.

29 ns has become a challenge for scientists and regulatory agencies alike.

30 this body of work would need to engage with regulatory agencies and bodies that formulate guidelines

31 gineered nanomaterials in consumer products, regulatory agencies and other research organizations hav

32 de first the approval of the new drug by the regulatory agencies and second the introduction of a mar

33 re, consultation with vaccine developers and regulatory agencies, and a collaborative workshop that g

34 effective work group representing industry, regulatory agencies, and academic and federal science, a

35 at typically assists in executing the trial, regulatory agencies, and academicians, provides inadequa

36 dentialing bodies, accrediting boards, state regulatory agencies, and care delivery organizations est

37 or reduced toxicity testing costs, demand by regulatory agencies, and ethical or moral concerns.

38 fore their marketing or formal approval from regulatory agencies, and for this reason their efficacy

39 ities, for example, governmental funding and regulatory agencies, and industry and clinician scientis

40 of providers along with government entities, regulatory agencies, and national organizations contribu

41 actions between various medical specialties, regulatory agencies, and researchers.

42 health providers, public and private payers, regulatory agencies, and standards-setting organizations

43 laws and lawmakers, including legislatures, regulatory agencies, and the courts.

44 Critical care practitioners, regulatory agencies, and the pharmaceutical industry agg

45 cacy, safety, and claims are not assessed by regulatory agencies, and there is uncertainty about thei

46 We recommend that regulatory agencies approve AEDs for the treatment of sp

47 a component of the inflammasome complex, to regulatory agency-approved IL-1-neutralizing biologic dr

48 ns and Web sites of various governmental and regulatory agencies are also reviewed.

49 Regulatory agencies are considering non-abstinent outcom

50 tical industry can influence governments and regulatory agencies are discussed, and methods by which

51 nd lysins, dialogues between researchers and regulatory agencies are necessary to publish guidelines

52 Biotechnological companies and regulatory agencies are pursuing the complete characteri

53 US and European regulatory agencies are recommending that sponsors study

54 By 2003, regulatory agencies began warning the public of unrecogn

55 ed through the effort of either (1) regional regulatory agencies by sharing and combining raw test da

56 Without increased access to regulatory agency data, publication bias will continue t

57 014, as well as other systematic reviews and regulatory agencies documentation.

58 Few analytes targeted by regulatory agencies (e.g., benzene or toluene) were obse

59 Efficacy data from drug regulatory agencies, e.g., the US Food and Drug Administ

60 We suggest that regulatory agencies (eg, US Food and Drug Administration

61 Public health authorities, regulatory agencies, food producers, and food processors

62 gnostic platform in hospitals and for use by regulatory agencies for better control of health-risks a

63 d not only by food manufacturers but also by regulatory agencies for better control of potential heal

64 approved by both US and European Commission regulatory agencies for clinical use, extends survival o

65 Regulatory agencies for each country should also aim tow

66 has potential to assist food industries and regulatory agencies for food quality control, allowing d

67 Monitoring of regulatory agencies for new drugs approvals ensures the

68 The algorithm includes drugs approved by regulatory agencies for the treatment of PAH and/or drug

69 the Royal College of Surgeons, established a regulatory agency for training and certification of surg

70 vel therapeutic agents approved by the three regulatory agencies from 2001 through 2010 and determine

71 Regulatory agencies generally do not consider outcomes r

72 ed data, the clinical research community and regulatory agencies have accepted the importance of a de

73 The medical community, the public, and even regulatory agencies have focused on specific preventable

74 conclude that systems failures by oversight-regulatory agencies in communication to active clinician

75 Guidance documents from regulatory agencies in Europe and the United States have

76 Guidance documents from regulatory agencies in Europe and the United States have

77 ition to specifically assist researchers and regulatory agencies in interpreting the clinical importa

78 cel-T and denosumab were approved in 2010 by regulatory agencies in the USA for men with metastatic C

79 phase 2 studies of new agents and may assist regulatory agencies in their evaluation and approval pro

80 that could prevent acceptance of results by regulatory agencies, including enrolment of heterogeneou

81 oponic production systems, and evaluation by regulatory agencies, including the CDC, FDA, and USDA, a

82 Nonanesthesiologists and governmental and regulatory agencies influence the delivery of sedation s

83 attempting clinical metabolic profiling, for regulatory agencies involved in the licensing of clinica

84 al following prior docetaxel and approval by regulatory agencies is anticipated.

85 This path, also supported by regulatory agencies, is calling for an important change

86 om patients' groups, academia, industry, and regulatory agencies-is aimed at addressing this shortfal

87 dolescents decreased after U.S. and European regulatory agencies issued warnings about a possible sui

88 ted from over 60 U.S. public health and food regulatory agency laboratories.

89 k in recently accumulated beebread was above regulatory agency levels of concern for acute or chronic

90 of vaccine stockpiles, increased support for regulatory agencies, maintenance and strengthening of li

91 mmunology (EAACI), experts from academia and regulatory agencies met with chamber operators to list t

92 n from the Medicines and Healthcare products Regulatory Agency (MHRA) required a dossier summarising

93 regulations are less stringent; however, US regulatory agencies must act to ensure patient safety.

94 Such commercial activity suggests that regulatory agencies must better oversee this marketplace

95 lized mechanisms be licensed by the national regulatory agency (NRA) in the producing country, then p

96 ndings are timely given the renewed focus of regulatory agencies on reproductive safety.

97 shed in peer-reviewed journals, presented by regulatory agencies, or presented as conference abstract

98 Clinical researchers, regulatory agencies, payers, and the public embrace the

99 s paper describes current interactions among regulatory agencies, payers, sponsors, and investigators

100 The reports are used by regulatory agencies, private insurance providers, transp

101 ioprocessing to safe limits as stipulated by regulatory agencies, rather than trying to eliminate all

102 Increased attention by the public and regulatory agencies regarding patient safety and quality

103 However, recommendations from regulatory agencies regarding the requirements for when

104 rs and clinicians; federal health officials; regulatory agency representatives; pharmaceutical, biote

105 for this interim analysis were collected per regulatory agencies' request as of June 30, 2017.

106 emic drugs in patients with type 2 diabetes, regulatory agencies require a comprehensive evaluation o

107 Therefore, clinicians, investigators, and regulatory agencies require improved understanding of th

108 armaceutical and biotechnology companies and regulatory agencies require novel methods to determine t

109 itoring criteria, there are more options for regulatory agencies seeking to protect beachgoers from w

110 Regulatory agencies should collaboratively develop proce

111 Payers and regulatory agencies should risk-adjust hospital cost ass

112 Researchers and regulatory agencies should work together to determine wh

113 he US Food and Drug Administration and other regulatory agencies since 2008.

114 nd hallucinations) and have been approved by regulatory agencies since the 1950s.

115 mendations from MAQC-II should be useful for regulatory agencies, study committees and independent in

116 Despite calls for TGC by various experts and regulatory agencies, supporting data remain somewhat inc

117 ive and balanced system, the use of existing regulatory agencies that oversee solid organs should pro

118 osteonecrosis were disseminated by national regulatory agencies, the manufacturers of bisphosphonate

119 Despite guidelines for testing from regulatory agencies, these interactions are usually disc

120 provide science-based information desired by regulatory agencies to address public concerns about the

121 e pharmaceutical sector, 2) partnership with regulatory agencies to arrive at meaningful outcomes for

122 ll, public concern motivated the company and regulatory agencies to commission several research studi

123 rmaceutical and biotechnology companies, and regulatory agencies to facilitate the development of new

124 s stakeholders in the agriculture sector and regulatory agencies to focus risk management efforts on

125 pixaban) have been approved by international regulatory agencies to treat atrial fibrillation and ven

126 form near-term technology decisions at state regulatory agencies, utilities, and pipeline companies,

127 pe 1 diabetes submitted to U.S. and European regulatory agencies, we recommend use of our definition.

128 -databases of planned and ongoing trials-and regulatory agency websites such as the European Medicine

129 f Science, Embase, CINAHL, PsycINFO, LiLACS, regulatory agencies' websites, and international registe

130 % loads calculated by methodology adopted by regulatory agencies were found to underestimate PM(2.5)

131 move into the 21st century, professional and regulatory agencies will be seeking to expand process me

132 otherapy studies and immunogenicity testing, regulatory agencies will progressively increasingly dema

133 agencies and donors, vaccine manufacturers, regulatory agencies, World Health Organization (WHO) and